ACUTE-GRAFT-VERSUS-HOST DISEASE
Clinical trials for ACUTE-GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE-GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE-GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes pill may shield transplant patients from dangerous rejection
Disease control CompletedThis study tested if adding the diabetes drug sitagliptin to standard medications could better prevent a dangerous immune reaction called graft-versus-host disease (GVHD) after a stem cell transplant. It involved 190 adults with blood cancers who received transplants from partial…
Matched conditions: ACUTE-GRAFT-VERSUS-HOST DISEASE
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 04, 2026 06:36 UTC
-
Stem cell breakthrough tested for deadly transplant complication
Disease control CompletedThis study tested whether adding umbilical cord stem cells to standard steroid treatment could better control acute graft-versus-host disease (GVHD) in transplant patients. Researchers enrolled 26 patients who developed moderate to severe GVHD after bone marrow transplants. They …
Matched conditions: ACUTE-GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Cytopeutics Sdn. Bhd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Experimental stem cell therapy tested for deadly transplant complication
Disease control CompletedThis early-stage study tested the safety of stem cells from umbilical cords for treating severe graft-versus-host disease (GVHD), a dangerous complication that can occur after a bone marrow transplant. The study involved 24 adults who developed severe GVHD that didn't respond to …
Matched conditions: ACUTE-GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC